Cerebral aspergillosis in systemic lupus erythematosus.
Gaubitz
M
M
Department of Medicine B, University of Münster, Germany. gaubitz@uni-muenster.de
Moskopp
D
D
Fegeler
W
W
Hilker
E
E
Domschke
W
W
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001921:Brain / Q000382:microbiology / Q000473:pathology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017964:Itraconazole / Q000627:therapeutic use; D008081:Liposomes; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D020953:Neuroaspergillosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D014057:Tomography, X-Ray Computed
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D008081:Liposomes; D017964:Itraconazole; D000666:Amphotericin B; D003520:Cyclophosphamide